Concomitant attenuation of HMG-CoA reductase expression potentiates the cancer cell growth-inhibitory effect of statins and expands their efficacy in tumor cells with epithelial characteristics
Takuro Ishikawa(Tottori University), Katsuhiko Warita(Tottori University)
Cited by 29
Related Papers
Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion
|Scientific Reports|2014|145
Repurposing of the Cardiovascular Drug Statin for the Treatment of Cancers: Efficacy of Statin–Dipyridamole Combination Treatment in Melanoma Cell Lines
|Biomedicines|2024|12
CYP11A1 silencing suppresses HMGCR expression via cholesterol accumulation and sensitizes CRPC cell line DU-145 to atorvastatin
|Journal of Pharmacological Sciences|2023|4
Atorvastatin exhibits anticancer effects by inhibiting YAP/TAZ activity in mesenchymal-like non-small cell lung cancer
|Scientific Reports|2025|3
Chondroitin sulfate E downregulates N-cadherin and suppresses myotube formation
|Journal of Veterinary Medical Science|2022|2